🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Leo Yamada

National Institutes of Health

ORCID: 0000-0003-0179-4802

Also affiliated with National Cancer Institute, Center for Cancer Research

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Δ133p53α-mediated inhibition of astrocyte senescence and neurotoxicity as a possible therapeutic approach for neurodegenerative diseases”.

Δ133p53α-mediated inhibition of astrocyte senescence and neurotoxicity as a possible therapeutic approach for neurodegenerative diseases

Neuroscience(2025)10.1016/j.neuroscience.2025.06.031

N/A

0DataRank · unranked

6 citations

Leo Yamada, Brent T. Harris, Curtis C. Harris, Izumi Horikawa

A Quantitative High-Throughput Screen Identifies Compounds that Upregulate the p53 Isoform Δ133p53α and Inhibit Cellular Senescence

ACS Pharmacology & Translational Science(2025)10.1021/acsptsci.5c00186

N/A

0DataRank · unranked

3 citations

Sebastien M. Joruiz, Patricia Dranchak, Kyra Ungerleider, Leo Yamada, Izumi Horikawa +8 more

SRSF3 knockdown-induced cellular senescence as a possible therapeutic strategy for non-small cell lung cancer

Carcinogenesis(2025)10.1093/carcin/bgaf082

N/A

0DataRank · unranked

1 citations

Natalia von Muhlinen, Leo Yamada, Jilian R. Melamed, Tyler E. Papp, Hamideh Parhiz +4 more

SRSF3 knockdown-induced cellular senescence as a possible therapeutic strategy for non-small cell lung cancer

bioRxiv (Cold Spring Harbor Laboratory)(2025)10.1101/2025.05.05.652234

N/A

0DataRank · unranked

2 citations

Natalia von Muhlinen, Leo Yamada, Jilian R. Melamed, Tyler E. Papp, Hamideh Parhiz +4 more